Bumper Offer - Urjas oil Just @ Rs. 1
Cyblex MV 40.2 Tablet (15) is a prescription medicine that is available as a Tablet. The alternative uses of Cyblex MV 40.2 Tablet (15) have also been explained below.
The right dosage of Cyblex MV 40.2 Tablet (15) depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Cyblex MV 40.2 Tablet (15) are Rash, Flatulence, Diarrhoea. Apart from the aforementioned side effects, Cyblex MV 40.2 Tablet (15) can also lead to other problems, which have been listed below. Usually, these side effects of Cyblex MV 40.2 Tablet (15) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Cyblex MV 40.2 Tablet (15)'s effect during pregnancy is Severe and Severe while nursing. It is important to know if Cyblex MV 40.2 Tablet (15) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Cyblex MV 40.2 Tablet (15) related warnings section.
Cyblex MV 40.2 Tablet (15) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Cyblex MV 40.2 Tablet (15) in conditions like Digestive Disorders, Intestinal Obstruction, Allergy. Other conditions have been mentioned below in the Cyblex MV 40.2 Tablet (15) contraindications section.
Additionally, Cyblex MV 40.2 Tablet (15) may also adversely react with other medicines. See below for a complete list.
You should also be aware that Cyblex MV 40.2 Tablet (15) is safe while driving, and is addiction.
Cyblex MV 40.2 Tablet (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Cyblex MV 40.2 Tablet (15) is used -
Severe
Moderate
Mild
Common
Is the use of Cyblex MV 40.2 Tablet (15) safe for pregnant women?
Cyblex Mv has many dangerous side effects in pregnant women. If you are pregnant, do not consume Cyblex Mv without medical advice.
Is the use of Cyblex MV 40.2 Tablet (15) safe during breastfeeding?
Taking Cyblex Mv may lead to serious side effects if you are breastfeeding. Cyblex Mv should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Cyblex MV 40.2 Tablet (15) on the Kidneys?
There can be some harmful effects on your kidneys after taking Cyblex Mv. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Cyblex MV 40.2 Tablet (15) on the Liver?
Cyblex Mv can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Cyblex MV 40.2 Tablet (15) on the Heart?
Side effects of Cyblex Mv rarely affect the heart.
Cyblex MV 40.2 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Cyblex MV 40.2 Tablet (15) unless your doctor advises you to do so -
Is this Cyblex MV 40.2 Tablet (15) habit forming or addictive?
Forming a habit of Cyblex MV 40.2 Tablet (15) has not been reported.
Interaction between Food and Cyblex MV 40.2 Tablet (15)
There is no information on the effects of taking Cyblex MV 40.2 Tablet (15) with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Cyblex MV 40.2 Tablet (15)
Taking Cyblex MV 40.2 Tablet (15) with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826